Prevalence of thyroid disorders among older people: results from the Sao Paulo Ageing & Health Study

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorBENSENOR, Isabela M.
dc.contributor.authorGOULART, Alessandra Carvalho
dc.contributor.authorLOTUFO, Paulo A.
dc.contributor.authorMENEZES, Paulo Rossi
dc.contributor.authorSCAZUFCA, Marcia
dc.date.accessioned2017-11-27T16:23:21Z
dc.date.available2017-11-27T16:23:21Z
dc.date.issued2011
dc.description.abstractThis study aimed to estimate prevalence of thyroid disorders in the Sao Paulo Ageing & Health Study, an epidemiological study addressing several health-adverse outcomes among elderly people living in a poor area of Sao Paulo, Brazil. All participants answered a questionnaire and had a blood sample collected to assess levels of tireotropic hormone and free-thyroxine. Among 1,373 people (60.8% women), prevalence rates (95% confidence interval) for thyroid dysfunction (%) were: overt hyperthyroidism, 0.7% (0.2-1.1) [women: 0.8% (0.2-1.5); men: 0.4% (0.01-0.9)]; overt hypothyroidism, 5.7% (4.5-6.9) [women: 5.9% (4.3-7.5); men: 5.4% (3.5-7.3)]; subclinical hyperthyroidism, 2.4% (1.6-3.2) [women: 2.8% (1.6-3.9); men: 1.9% (0.7-3.0)]; and subclinical hypothyroidism, 6.5% (5.2-7.8) [women: 6.7% (5.0-8.4); men: 6.1% (4.1-8.2)]. There was no difference in prevalence rates according to gender, but almost 40% of women were diagnosed and under treatment compared to 9% of men. The burden of thyroid disorders in this sample is high and most participants were not aware of them.
dc.description.abstractO objetivo da pesquisa foi avaliar a prevalência de doenças da tireóide no São Paulo Ageing & Health Study, estudo epidemiológico focado em desfechos de saúde adversos em amostra de idosos moradores de São Paulo, Brasil. Todos os participantes responderam a questionário e colheram sangue para dosagem de hormônio tireotrópico e tiroxina-livre. Entre os 1.373 participantes (60,8% mulheres), a prevalência (intervalo de 95% de confiança) de hipertireoidismo clínico foi de 0,7% (0.2-1,1) [mulheres: 0,8% (0,2-1,5); homens: 0,4% (0,01-0,9)]; hipotireoidismo clínico, 5,7% (4,5-6,9) [mulheres: 5,9% (4,3-7,5); homens: 5,4% (3,5-7,3)]; hipertireoidismo subclínico, 2,4% (1,6-3,2) [mulheres: 2,8% (1,6-3,9); homens: 1,9% (0,7-3,0)]; e hipotireoidismo subclínico, 6,5% (5,2-7,8) [mulheres: 6,7% (5,0-8,4); homens: 6,1% (4,1-8,2)]. Não houve diferença na prevalência de doenças da tireóide por sexo. Quarenta por cento das mulheres tinham diagnóstico e estavam tratando, comparadas a 9% dos homens. A prevalência de disfunção tireoidiana foi elevada e a maioria dos participantes desconhecia o diagnóstico.
dc.description.indexMEDLINE
dc.description.sponsorshipSao Paulo State Research Foundation (FAPESP)
dc.description.sponsorshipWellcome Trust
dc.identifier.citationCADERNOS DE SAUDE PUBLICA, v.27, n.1, p.155-161, 2011
dc.identifier.issn0102-311X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/22558
dc.language.isoeng
dc.publisherCADERNOS SAUDE PUBLICA
dc.relation.ispartofCadernos de Saude Publica
dc.rightsopenAccess
dc.rights.holderCopyright CADERNOS SAUDE PUBLICA
dc.subjectThyroid Diseases
dc.subjectAged
dc.subjectHyperthyroidism
dc.subjectHypothyroidism
dc.subjectDoenças da Glândula Tireóide
dc.subjectIdoso
dc.subjectHipertireoidismo
dc.subjectHipotireoidismo
dc.subject.othersubclinical hypothyroidism
dc.subject.otherrisk-factor
dc.subject.otherdisease
dc.subject.otherbrazil
dc.subject.otherwomen
dc.subject.othercare
dc.subject.wosPublic, Environmental & Occupational Health
dc.titlePrevalence of thyroid disorders among older people: results from the Sao Paulo Ageing & Health Study
dc.title.alternativePrevalência de doenças da tireóide em idosos: resultados do São Paulo Ageing & Health Study
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcISABELA JUDITH MARTINS BENSEñOR
hcfmusp.contributor.author-fmusphcALESSANDRA CARVALHO GOULART
hcfmusp.contributor.author-fmusphcPAULO ANDRADE LOTUFO
hcfmusp.contributor.author-fmusphcPAULO ROSSI MENEZES
hcfmusp.contributor.author-fmusphcMARCIA SCAZUFCA
hcfmusp.description.beginpage155
hcfmusp.description.endpage161
hcfmusp.description.issue1
hcfmusp.description.volume27
hcfmusp.origemWOS
hcfmusp.origem.pubmed21340114
hcfmusp.origem.wosWOS:000287922700016
hcfmusp.publisher.cityRIO DE JANIERO
hcfmusp.publisher.countryBRAZIL
hcfmusp.relation.reference*AG HEALTHC RES QU, SCREEN THYR DIS
hcfmusp.relation.referenceAndersen-Ranberg K, 1999, J AM GERIATR SOC, V47, P1238
hcfmusp.relation.referenceAnjum Qudsia, 2006, JPMA Journal of the Pakistan Medical Association, V56, P13
hcfmusp.relation.referenceParle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6
hcfmusp.relation.referenceHak AE, 2000, ANN INTERN MED, V132, P270
hcfmusp.relation.referenceHollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
hcfmusp.relation.referenceBEMBEN DA, 1994, J FAM PRACTICE, V38, P577
hcfmusp.relation.referenceScazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625
hcfmusp.relation.referenceLadenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573
hcfmusp.relation.referenceCanaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526
hcfmusp.relation.referenceScazufca M, 2008, INT J EPIDEMIOL, V37, P721, DOI 10.1093/ije/dym154
hcfmusp.relation.referenceLuboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512
hcfmusp.relation.referenceSAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386
hcfmusp.relation.referenceGussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591
hcfmusp.relation.referenceAQUINO EML, 1992, REV SAUDE PUBL, V26, P195
hcfmusp.relation.referenceBAHEMUKA M, 1975, BRIT MED J, V2, P601
hcfmusp.relation.reference*CAN TASK FORC PRE, CAN TASK FORC PER HL
hcfmusp.relation.referenceDanese MD, 1996, JAMA-J AM MED ASSOC, V276, P285, DOI 10.1001/jama.276.4.285
hcfmusp.relation.referenceKOUTIS A D, 1991, Scandinavian Journal of Primary Health Care, V9, P297, DOI 10.3109/02813439109018536
hcfmusp.relation.referenceSAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901
hcfmusp.relation.referenceStoverinck MJM, 1996, J FAM PRACTICE, V43, P567
hcfmusp.relation.reference1998, ANN INTERN MED, V129, P141
relation.isAuthorOfPublication6911f59e-7ec9-4ad2-b746-580bf8b3d64d
relation.isAuthorOfPublicationcd675f04-b4ad-47f1-8d3c-15f6cb73d8cf
relation.isAuthorOfPublicationcb0c8dbb-6df5-4294-8d8e-e96645a3cec1
relation.isAuthorOfPublicationc2332a62-89bc-4097-82d9-87c1fe2e75dc
relation.isAuthorOfPublicationdb37e466-8edc-4399-80fc-61e01f88017f
relation.isAuthorOfPublication.latestForDiscovery6911f59e-7ec9-4ad2-b746-580bf8b3d64d
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_BENSENOR_Prevalence_of_thyroid_disorders_among_older_people_results_2011.PDF
Tamanho:
92.34 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)